Selected research
Industry Research
Codeine Drug Industry Research Report 2026
Market perspective
The global Codeine Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Codeine Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Codeine Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Codeine Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Codeine Drug include Apotex, Aristo Pharma GmbH, Cipla, Hikma, Laboratoire Riva, Lannett Company, Mallinckrodt, Medreich and Pharmaceutical Associates, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Codeine Drug market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Codeine Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Codeine Drug Market by Company
Apotex
Aristo Pharma GmbH
Cipla
Hikma
Laboratoire Riva
Lannett Company
Mallinckrodt
Medreich
Pharmaceutical Associates
Sanofi Aventis
Taiji
Viatris
Novartis
Johnson & Johnson
TEVA
Codeine Drug Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications Codeine
Codeine Drug Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Codeine Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-ingredient Codeine
- Multi-ingredient Medications Codeine
Applications
- Narcotic Analgesic
- Antitussive
- Others
Companies covered
- Apotex
- Aristo Pharma GmbH
- Cipla
- Hikma
- Laboratoire Riva
- Lannett Company
- Mallinckrodt
- Medreich
- Pharmaceutical Associates
- Sanofi Aventis
- Taiji
- Viatris
- Novartis
- Johnson & Johnson
- TEVA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Codeine Drug by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single-ingredient Codeine
- 2.2.3 Multi-ingredient Medications Codeine
- 2.3 Codeine Drug by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Narcotic Analgesic
- 2.3.3 Antitussive
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Codeine Drug Breakdown Data by Type
- 3.1 Global Codeine Drug Historic Market Size by Type (2021-2026)
- 3.2 Global Codeine Drug Forecasted Market Size by Type (2027-2032)
4 Codeine Drug Breakdown Data by Application
- 4.1 Global Codeine Drug Historic Market Size by Application (2021-2026)
- 4.2 Global Codeine Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Codeine Drug Market Perspective (2021-2032)
- 5.2 Global Codeine Drug Growth Trends by Region
- 5.2.1 Global Codeine Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Codeine Drug Historic Market Size by Region (2021-2026)
- 5.2.3 Codeine Drug Forecasted Market Size by Region (2027-2032)
- 5.3 Codeine Drug Market Dynamics
- 5.3.1 Codeine Drug Industry Trends
- 5.3.2 Codeine Drug Market Drivers
- 5.3.3 Codeine Drug Market Challenges
- 5.3.4 Codeine Drug Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Codeine Drug Players by Revenue
- 6.1.1 Global Top Codeine Drug Players by Revenue (2021-2026)
- 6.1.2 Global Codeine Drug Revenue Market Share by Players (2021-2026)
- 6.2 Global Codeine Drug Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Codeine Drug Head Office and Area Served
- 6.4 Global Codeine Drug Players, Product Type & Application
- 6.5 Global Codeine Drug Manufacturers Established Date
- 6.6 Global Codeine Drug Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Codeine Drug Market Size (2021-2032)
- 7.2 North America Codeine Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Codeine Drug Market Size by Country (2021-2026)
- 7.4 North America Codeine Drug Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Codeine Drug Market Size (2021-2032)
- 8.2 Europe Codeine Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Codeine Drug Market Size by Country (2021-2026)
- 8.4 Europe Codeine Drug Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Codeine Drug Market Size (2021-2032)
- 9.2 Asia-Pacific Codeine Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Codeine Drug Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Codeine Drug Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Codeine Drug Market Size (2021-2032)
- 10.2 South America Codeine Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Codeine Drug Market Size by Country (2021-2026)
- 10.4 South America Codeine Drug Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Codeine Drug Market Size (2021-2032)
- 11.2 Middle East & Africa Codeine Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Codeine Drug Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Codeine Drug Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Apotex
- 12.1.1 Apotex Company Information
- 12.1.2 Apotex Business Overview
- 12.1.3 Apotex Revenue in Codeine Drug Business (2021-2026)
- 12.1.4 Apotex Codeine Drug Product Portfolio
- 12.1.5 Apotex Recent Developments
- 12.2 Aristo Pharma GmbH
- 12.2.1 Aristo Pharma GmbH Company Information
- 12.2.2 Aristo Pharma GmbH Business Overview
- 12.2.3 Aristo Pharma GmbH Revenue in Codeine Drug Business (2021-2026)
- 12.2.4 Aristo Pharma GmbH Codeine Drug Product Portfolio
- 12.2.5 Aristo Pharma GmbH Recent Developments
- 12.3 Cipla
- 12.3.1 Cipla Company Information
- 12.3.2 Cipla Business Overview
- 12.3.3 Cipla Revenue in Codeine Drug Business (2021-2026)
- 12.3.4 Cipla Codeine Drug Product Portfolio
- 12.3.5 Cipla Recent Developments
- 12.4 Hikma
- 12.4.1 Hikma Company Information
- 12.4.2 Hikma Business Overview
- 12.4.3 Hikma Revenue in Codeine Drug Business (2021-2026)
- 12.4.4 Hikma Codeine Drug Product Portfolio
- 12.4.5 Hikma Recent Developments
- 12.5 Laboratoire Riva
- 12.5.1 Laboratoire Riva Company Information
- 12.5.2 Laboratoire Riva Business Overview
- 12.5.3 Laboratoire Riva Revenue in Codeine Drug Business (2021-2026)
- 12.5.4 Laboratoire Riva Codeine Drug Product Portfolio
- 12.5.5 Laboratoire Riva Recent Developments
- 12.6 Lannett Company
- 12.6.1 Lannett Company Company Information
- 12.6.2 Lannett Company Business Overview
- 12.6.3 Lannett Company Revenue in Codeine Drug Business (2021-2026)
- 12.6.4 Lannett Company Codeine Drug Product Portfolio
- 12.6.5 Lannett Company Recent Developments
- 12.7 Mallinckrodt
- 12.7.1 Mallinckrodt Company Information
- 12.7.2 Mallinckrodt Business Overview
- 12.7.3 Mallinckrodt Revenue in Codeine Drug Business (2021-2026)
- 12.7.4 Mallinckrodt Codeine Drug Product Portfolio
- 12.7.5 Mallinckrodt Recent Developments
- 12.8 Medreich
- 12.8.1 Medreich Company Information
- 12.8.2 Medreich Business Overview
- 12.8.3 Medreich Revenue in Codeine Drug Business (2021-2026)
- 12.8.4 Medreich Codeine Drug Product Portfolio
- 12.8.5 Medreich Recent Developments
- 12.9 Pharmaceutical Associates
- 12.9.1 Pharmaceutical Associates Company Information
- 12.9.2 Pharmaceutical Associates Business Overview
- 12.9.3 Pharmaceutical Associates Revenue in Codeine Drug Business (2021-2026)
- 12.9.4 Pharmaceutical Associates Codeine Drug Product Portfolio
- 12.9.5 Pharmaceutical Associates Recent Developments
- 12.10 Sanofi Aventis
- 12.10.1 Sanofi Aventis Company Information
- 12.10.2 Sanofi Aventis Business Overview
- 12.10.3 Sanofi Aventis Revenue in Codeine Drug Business (2021-2026)
- 12.10.4 Sanofi Aventis Codeine Drug Product Portfolio
- 12.10.5 Sanofi Aventis Recent Developments
- 12.11 Taiji
- 12.11.1 Taiji Company Information
- 12.11.2 Taiji Business Overview
- 12.11.3 Taiji Revenue in Codeine Drug Business (2021-2026)
- 12.11.4 Taiji Codeine Drug Product Portfolio
- 12.11.5 Taiji Recent Developments
- 12.12 Viatris
- 12.12.1 Viatris Company Information
- 12.12.2 Viatris Business Overview
- 12.12.3 Viatris Revenue in Codeine Drug Business (2021-2026)
- 12.12.4 Viatris Codeine Drug Product Portfolio
- 12.12.5 Viatris Recent Developments
- 12.13 Novartis
- 12.13.1 Novartis Company Information
- 12.13.2 Novartis Business Overview
- 12.13.3 Novartis Revenue in Codeine Drug Business (2021-2026)
- 12.13.4 Novartis Codeine Drug Product Portfolio
- 12.13.5 Novartis Recent Developments
- 12.14 Johnson & Johnson
- 12.14.1 Johnson & Johnson Company Information
- 12.14.2 Johnson & Johnson Business Overview
- 12.14.3 Johnson & Johnson Revenue in Codeine Drug Business (2021-2026)
- 12.14.4 Johnson & Johnson Codeine Drug Product Portfolio
- 12.14.5 Johnson & Johnson Recent Developments
- 12.15 TEVA
- 12.15.1 TEVA Company Information
- 12.15.2 TEVA Business Overview
- 12.15.3 TEVA Revenue in Codeine Drug Business (2021-2026)
- 12.15.4 TEVA Codeine Drug Product Portfolio
- 12.15.5 TEVA Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst